Zwitterionic polysaccharide polymers having antifouling, antimicrobial and optical transparency properties
US-2016251470-A1 · Sep 1, 2016 · US
US2017145120A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017145120-A1 |
| Application number | US-201515319736-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 19, 2015 |
| Priority date | Jun 20, 2014 |
| Publication date | May 25, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject matter of the invention is dextrans which have between 95% and 99% of α-1,6 glucosidic bonds, a weight-average molar mass M w at least equal to 0.7×10 9 g.mol −1 , and a dispersity index D of between 1.3 and 3. The invention also relates to a dextran saccharase which makes it possible to produce such dextrans, and to a method for producing said dextrans.
Opening claim text (preview).
1 . Dextrans having a weight-average molar mass M w at least equal to 0.7×10 9 g.mol −1 , and a dispersity index D i of between 1.3 and 3, wherein α-1,6 glucosidic bonds in the dextrans comprise (i) between 95% and 99% of glucosidic bonds, (ii) between 97% and 98% of glucosidic bonds, or (iii) between 97.4% and 97.6%, of glucosidic bonds. 2 . The dextrans of claim 1 , having a weight-average molar mass M w at least equal to 1×10 9 g.mol −1 . 3 . A dextransucrase that is selected from: (i) a dextransucrase comprising the amino acid sequence set forth in SEQ ID NO: 1, (ii) a function-preserving dextransucrase variant having at least 80% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (iii) a function-preserving dextransucrase variant having at least 85% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (iv) a function-preserving dextransucrase variant having at least 90% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (v) a function-preserving dextransucrase variant having at least 95% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (vi) a function-preserving dextransucrase variant having at least 98% sequence identity positions 359 to 1038 of the amino acid sequence SEQ ID NO: 1, and (vii) the dextransucrase or function-preserving dextransucrase variant of any one of (i)-(vi) fused to a purification tag. 4 . A process for producing the dextrans of claim 1 , comprising reacting sucrose with a dextransucrase that is selected from: (i) a dextransucrase comprising the amino acid sequence set forth in SEQ ID NO: 1, (ii) a function-preserving dextransucrase variant having at least 80% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (iii) a function-preserving dextransucrase variant having at least 85% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (iv) a function-preserving dextransucrase variant having at least 90% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (vi) a function-preserving dextransucrase variant having at least 95% sequence identity with positions 359 to 1038 of the amino acid sequence set forth in SEQ ID NO: 1, (vi) a function-preserving dextransucrase variant having at least 98% sequence identity positions 359 to 1038 of the amino acid sequence SEQ ID NO: 1, and (vii) the dextransucrase or function-preserving dextransucrase variant of any one of (i)-(vi) fused to a purification tag. 5 . The process of claim 4 , wherein the step of reacting is carried out (i) at a temperature of between 20° C. and 40° C., (ii) at a temperature of between 25° C. and 35° C., or (iii) at a temperature of between 30° C. and 33° C. 6 . The process of claim 4 , wherein (i) the sucrose is present at a concentration that is between approximately 50 and 200 g.l −1 , or (ii) the sucrose is present at a concentration that is between approximately 50 and 150 g.l −1 . 7 . The process of claim 4 , wherein (i) pH during the step of reacting is between approximately 5 and 6.5, (ii) pH during the step of reacting is between 5 and 6, or (iii) pH during the step of reacting is between 5 and 5.8. 8 . A cosmetic or food composition comprising the dextrans of claim 1 and at least one pharmaceutically acceptable or food-grade support. 9 . A method for thickening, gelling and/or texturizing, a composition, comprising introducing into the composition the dextrans of claim 1 , as a thickener, gelling agent and/or texturing agent.
Preparations for care of the skin · CPC title
Polysaccharides · CPC title
Hexosyltransferases (2.4.1) · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.